Medtech companies operating in China are being advised to prepare for significant revisions the Chinese regulator has made to its 2002 Medical Device Classification Catalogue, which will become effective on Aug. 1, 2018.
The China Food and Drug Administration announced the final revision to the classification catalogue on Aug. 31, according to Katherine Wang, a partner at the Shanghai office of law firm...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?